Posts With Tag shareholder approval

AstraZeneca's 6-K filing details the approval of new articles of association, enhancing capital access. Key voting results and future trading updates included.

Explore Galapagos NV's Form 6-K for February 2025, detailing the Separation Agreement with Gilead and implications for shareholders. Key risks and forward-looking statements included.